Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    19065567 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated SU5416 in Treating Children With Recurrent or Progressive Brain Tumors
Condition: Brain and Central Nervous System Tumors
Intervention: Drug: semaxanib

Study has passed its completion date and status has not been verified in more than two years.